ArticlePloS one2021

The glutaminase inhibitor telaglenastat enhances the antitumor activity of signal transduction inhibitors everolimus and cabozantinib in models of renal cell carcinoma.

Ethan Emberley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.